Skip to content

Effect of Jatamansi powder orally in hyperactive children for a period of 4 weeks

Comparative clinical trial on the add on effect of Jatamansi Churna in hyperactive children - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084561
Enrollment
40
Registered
2025-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F901- Attention-deficit hyperactivity disorder, predominantly hyperactive type

Interventions

None listed

Sponsors

Dr Chaithanya B M
Lead Sponsor
JSS Ayurveda Medical College and Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children between the age of 5-15 years irrespective of gender, religion and socioeconomic status. 2. Already diagnosed cases of ADHD and ASD with hyperactivity and sleep disturbances. 3. New cases fulfilling the diagnostic criteria as per DSM 5. 4. Children whose parents / guardian are willing to give written informed assent.

Exclusion criteria

Exclusion criteria: 1. Any co existing Systemic and Developmental disorders 2. Known cases of any genetic disorders. 3. Diagnosed cases of psychological illness.

Design outcomes

Primary

MeasureTime frame
Add on effect of jatamansi churna in reducing hyperactivity as per scores of CGI,CGAS,Sleep disturbance scaleTimepoint: 0th day,14th day , 29th day

Secondary

MeasureTime frame
effect of jatamansi in reducing hyperactivity as per scores of CGI,CGAS, Sleep disturbance scaleTimepoint: 0th day, 14th day, 29th day

Countries

India

Contacts

Public ContactDr Jyothy K B

JSS Ayurveda Medical College and Hospital

jyothybmenon@yahoo.com7776014076

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026